Evolva Holding Valuation
Is EVEZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EVEZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate EVEZ's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate EVEZ's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EVEZ?
Key metric: As EVEZ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is EVEZ's PS Ratio? | |
|---|---|
| PS Ratio | 1.8x |
| Sales | CHF 4.16m |
| Market Cap | CHF 7.28m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.3x |
| Enterprise Value/EBITDA | 0.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does EVEZ's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 4x | ||
GPL Graft Polymer (UK) | 12.9x | n/a | UK£4.5m |
DCTA Directa Plus | 1.2x | 43.5% | UK£9.1m |
SYM Symphony Environmental Technologies | 1.3x | n/a | UK£7.9m |
HDD Hardide | 0.7x | 13.8% | UK£3.4m |
EVEZ Evolva Holding | 1.8x | n/a | CHF 7.3m |
Price-To-Sales vs Peers: EVEZ is expensive based on its Price-To-Sales Ratio (1.8x) compared to the peer average (0.9x).
Price to Sales Ratio vs Industry
How does EVEZ's PS Ratio compare vs other companies in the GB Chemicals Industry?
Price-To-Sales vs Industry: EVEZ is expensive based on its Price-To-Sales Ratio (1.8x) compared to the UK Chemicals industry average (1.3x).
Price to Sales Ratio vs Fair Ratio
What is EVEZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.8x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate EVEZ's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Altri SGPS
€1.0b
Produces and sells cellulosic fibers and energy in Portugal and internationally.
0DJV
€5.05
7D
-2.6%
1Y
5.5%
Navigator Company
€2.5b
Manufactures and markets pulp and paper products worldwide.
0KLO
€3.51
7D
-4.6%
1Y
-7.0%
Elkem
NOK 11.6b
Engages in the provision of advanced material solutions worldwide.
0SFN
NOK 18.36
7D
1.7%
1Y
1.3%